Remote-First Company -- (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, will present at the 43rd Annual J.P. Morgan ...
Morgan Stanley initiated coverage of Hims Hers Health Inc (NYSE:HIMS) with an “overweight” rating and a $42 price target driven by strong growth prospects and operating leverage.
The machinery and construction industry on Tuesday was upgraded to Attractive from a prior investment rating of In-Line by analysts at financial-services firm Morgan Stanley. “We expect 2025 demand ...
Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that the U.S. Food and Drug ...
Medable Inc., the leading technology provider for modern clinical trials, today announced that Medable CEO and Co-Founder Michelle Longmire will be presenting a corporate update at the 43rd Annual J.P ...
Applying to business school because you feel pressured - by colleagues, your parents or anything else - will probably make for a lackluster application and a less-than-ideal experience, added Shaifali ...